XNYS
COP
Market cap131bUSD
Jul 09, Last price
108.02USD
1D
-2.44%
1Q
-11.86%
Jan 2017
115.44%
Name
Conocophillips
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
CompuGroup Medical SE & Co. KGaA (CGM) is a global developer and vendor of sophisticated information technology and software solutions tailored for the healthcare industry. The company organizes its diverse offerings into four primary operational segments: Ambulatory Information Systems (AIS): This segment furnishes physicians, medical centers, and professional networks with essential practice management software and electronic medical records. It also provides complementary internet and intranet-based tools to support outpatient care. Pharmacy Information Systems (PCS): Focusing on the pharmaceutical sector, PCS delivers administrative and billing software applications designed for pharmacies. These solutions offer critical information and decision-making support for managing the intricate medication supply chain. Hospital Information Systems (HIS): Catering to the inpatient environment, this segment provides comprehensive clinical and administrative solutions. Its clientele includes acute care hospitals, rehabilitation facilities, social service organizations, multi-site hospital networks, regional care providers, and medical laboratories. Consumer & Health Management Information Systems (CHS): This broad segment encompasses services such as IT security, data-driven product suites, interfaces for information exchange, clinical decision support tools, and extensive medication and treatment databases for healthcare service providers. Additionally, it develops digital healthcare platforms, consumer portals, and mobile applications, along with security measures for providers. Its customer base is expansive, covering pharmaceutical companies, health insurance providers, other healthcare IT firms, and direct consumers. Founded in 1987 and headquartered in Koblenz, Germany, the company officially adopted its current designation, CompuGroup Medical SE & Co. KGaA, in June 2020, having previously operated as CompuGroup Medical SE.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||